Value proposition

Basepaws is a pet genetics company that creates affordable, easy-to-use health tests for every pet parent.

Basepaws is a petcare genetics company that builds early detection health risk tests based on genetic and microbiome data. Basepaws is committed to companion animal health research, and it has the world’s first at-home genetic testing platform for cats. Founded in 2017 by Anna Skaya, the company is based in Los Angeles, CA.

On June 22, 2022, Zoetis Inc. (NYSE:ZTS) announced the completion of its acquisition of Basepaws. The acquisition was first announced on June 7th, and the financial terms of the transaction were not disclosed.

“The addition of Basepaws will enhance our portfolio in the precision animal health space and inform our future pipeline of petcare innovations. Working together, we can continue to provide veterinarians and pet owners with more comprehensive ways to proactively manage the health, wellness and quality of care for their animals.” - said Zoetis CEO Kristin Peck.

pettech, startup, biotech, feline health, animal health, microbiome, genetics, animal genetics, felines, cat behavior, and dental health